- Home
- PPC vs ASND Comparison
PPC vs ASND Comparison
Compare PPC & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPC
- ASND
- Stock Information
- Founded
- PPC 1946
- ASND 2006
- Country
- PPC United States
- ASND Denmark
- Employees
- PPC N/A
- ASND N/A
- Industry
- PPC Meat/Poultry/Fish
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- PPC Consumer Staples
- ASND Health Care
- Exchange
- PPC Nasdaq
- ASND Nasdaq
- Market Cap
- PPC 12.5B
- ASND 10.6B
- IPO Year
- PPC 1987
- ASND 2015
- Fundamental
- Price
- PPC $45.89
- ASND $174.18
- Analyst Decision
- PPC Hold
- ASND Strong Buy
- Analyst Count
- PPC 6
- ASND 17
- Target Price
- PPC $48.67
- ASND $220.06
- AVG Volume (30 Days)
- PPC 1.2M
- ASND 399.8K
- Earning Date
- PPC 07-30-2025
- ASND 09-02-2025
- Dividend Yield
- PPC 13.73%
- ASND N/A
- EPS Growth
- PPC 145.39
- ASND N/A
- EPS
- PPC 5.08
- ASND N/A
- Revenue
- PPC $17,979,366,000.00
- ASND $398,509,511.00
- Revenue This Year
- PPC $2.74
- ASND $75.05
- Revenue Next Year
- PPC $1.19
- ASND $78.14
- P/E Ratio
- PPC $9.03
- ASND N/A
- Revenue Growth
- PPC 2.40
- ASND 12.06
- 52 Week Low
- PPC $37.28
- ASND $111.09
- 52 Week High
- PPC $57.16
- ASND $183.00
- Technical
- Relative Strength Index (RSI)
- PPC 43.87
- ASND 51.75
- Support Level
- PPC $44.04
- ASND $167.52
- Resistance Level
- PPC $45.82
- ASND $174.34
- Average True Range (ATR)
- PPC 1.03
- ASND 5.45
- MACD
- PPC 0.12
- ASND -0.75
- Stochastic Oscillator
- PPC 52.21
- ASND 37.23
About PPC Pilgrim's Pride Corporation
Pilgrim's Pride is the second-largest poultry producer in the US (59% of 2024 sales), the UK (29% including other European sales), and Mexico (12%). Its UK and European arm also includes pork operations from the 2019 acquisition of Tulip. Pilgrim's sells to chain restaurants, food processors, food distributors, and retail chains. most of its US and Mexican sales come from fresh chicken, while prepared chicken and pork constitute most of its UK and European sales. JBS owns more than 80% of Pilgrim's Pride's outstanding shares, though it failed to acquire the remaining stake in 2021 after a special board committee deemed JBS' offer undervalued Pilgrim's Pride.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.